Clinical trial
13-Cis Retinoic Acid With or Without Vitamin E for Prevention of Lung Cancer
NCT00002586 · University of Colorado, Denver, Other · Completed
Key facts
| NCT number | NCT00002586 |
|---|---|
| Title | 13-Cis Retinoic Acid With or Without Vitamin E for Prevention of Lung Cancer |
| Official title | ASSESSMENT OF INTERMEDIATE ENDPOINT BIOMARKERS TO 13-CIS RETINOIC ACID WITH OR WITHOUT ALPHA TOCOPHEROL OR OBSERVATION |
| Acronym | 13-Cis |
| Lead sponsor | University of Colorado, Denver, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Drug Toxicity, Lung Cancer |
| Intervention type | Dietary Supplement, Drug |
| Interventions | 13-cis retinoic acid, Tocopherol |
| Enrollment | 96 |
| Start date | Jan 1, 1993 |
| Primary completion | Dec 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | May 15, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: